Quest Diagnostics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments.

CEO

James E. Davis

CEOJames E. Davis

Employees

48,000

Employees48,000

Headquarters

Secaucus, New Jersey

HeadquartersSecaucus, New Jersey

Founded

1967

Founded1967

Employees

48,000

Employees48,000

DGX Key Statistics

Market cap

15.07B

Market cap15.07B

Price-Earnings ratio

18.49

Price-Earnings ratio18.49

Dividend yield

2.10%

Dividend yield2.10%

Average volume

1.28M

Average volume1.28M

High today

$138.11

High today$138.11

Low today

$135.57

Low today$135.57

Open price

$137.70

Open price$137.70

Volume

718.56K

Volume718.56K

52 Week high

$145.58

52 Week high$145.58

52 Week low

$119.59

52 Week low$119.59

DGX News

Yahoo Finance 4d

Reasons to Retain Quest Diagnostics Stock for Now - Yahoo Finance

Quest Diagnostics Inc.‘s DGX legacy base business is significantly advancing its growth strategy with novel testing solutions and enhanced relationships with he...

Yahoo Finance 4d

Quest Diagnostics Inks Deal to Acquire PathAI Diagnostics - Yahoo Finance

Quest Diagnostics DGX recently announced a multi-faceted collaboration with PathAI to accelerate the adoption of digital and AI pathology innovations to improve...

Yahoo Finance 5d

Quest to ramp up AI capabilities with purchase of PathAI's diagnostic lab - Yahoo Finance

Dive Brief: Quest Diagnostics said Wednesday it will buy PathAI’s diagnostic laboratory as part of a deal designed to “dramatically ramp” its capabilities in a...

Analyst ratings

70%

of 20 ratings

Buy

30%

Hold

70%

Sell

More DGX News

TipRanks 5d

Quest Diagnostics to acquire certain assets of PathAI

Quest Diagnostics and PathAI announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve qual...

TipRanks 6d

Final LDT rule lifts overhang on Quest and Labcorp, says Jefferies

Jefferies notes that the FDA announced a final rule detailing its planned future regulation of laboratory developed tests, or “LDTs.” While the final rule follo...